Rockwell Medical, Inc.
RMTI
$7.96
-$0.11-1.30%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 21.45% | -5.94% | 26.72% | -205.35% | -534.99% |
| Total Depreciation and Amortization | -12.61% | -5.19% | 0.55% | 0.18% | 2.55% |
| Total Amortization of Deferred Charges | 2.27% | 0.00% | 0.00% | 1.14% | 193.33% |
| Total Other Non-Cash Items | -20.47% | -7.90% | -20.83% | -20.18% | 26.09% |
| Change in Net Operating Assets | 9.38% | 94.38% | 28,520.00% | -230.60% | 1,047.62% |
| Cash from Operations | 12.80% | 95.21% | 164.86% | -130.57% | 27.88% |
| Capital Expenditure | -276.22% | -574.60% | 78.23% | -19.90% | 42.66% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 113.11% | 106.45% | -6,520.63% | 31.09% | -96.95% |
| Cash from Investing | -372.82% | -12,100.00% | -1,144.28% | 29.50% | -106.00% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 14.88% | 9.80% | 9.91% | 5.57% | -55.80% |
| Issuance of Common Stock | -- | -- | -100.00% | 115.32% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -14.94% | -14.68% | -14.85% | 23.16% | -- |
| Cash from Financing | -5.08% | -3.83% | -137.93% | 191.57% | -131.48% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -16.59% | 74.20% | -187.21% | 137.47% | -79.10% |